Dydrogesterone exposure induces zebrafish ovulation but leads to oocytes over-ripening: An integrated histological and metabolomics study.
Animals
Dose-Response Relationship, Drug
Dydrogesterone
/ adverse effects
Embryo, Nonmammalian
/ drug effects
Endocrine Disruptors
/ adverse effects
Metabolome
/ drug effects
Metabolomics
Oocytes
/ drug effects
Ovulation
/ drug effects
Progestins
/ adverse effects
Random Allocation
Reproduction
/ drug effects
Sex Ratio
Water Pollutants, Chemical
/ adverse effects
Zebrafish
/ physiology
5-Oxo-ETE
Dydrogesterone
Oocyte maturation
Over-ripening
Ovulation
Purinergic signaling
Journal
Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
14
01
2019
revised:
25
04
2019
accepted:
25
04
2019
pubmed:
13
5
2019
medline:
8
11
2019
entrez:
13
5
2019
Statut:
ppublish
Résumé
Dydrogesterone (DDG) is a synthetic progestin widely used in numerous gynecological diseases. DDG has been shown to disturb fish reproduction, however, the mechanism is still unclear. Here we studied the histological changes and differences of metabolome between exposed and control fish gonads after exposure of zebrafish (Danio rerio) embryos to 2.8, 27.6, and 289.8 ng/L DDG until sexual maturity for a total of 140 days. Dydrogesterone exposure led to male-biased zebrafish sex ratios. Histological examination revealed that DDG induced postovulatory follicles and atretic follicles in the ovary of the female fish. Postovulatory follicles indicated the occurrence of ovulation. DDG also increased spermatids and spermatozoa in the male fish testis, suggesting promotion of spermatogenesis. Ovarian metabolome showed that DDG increased the concentrations of free amino acids, urea, putrescine, free fatty acids, acylcarnitines, lysophospholipids, and other metabolites catabolized from phospholipids. Most of these metabolites are biodegradation products of proteins and lipids, suggesting the existence of ovulated oocytes over-ripening. Further, DDG upregulated arachidonic acid (AA) and its 5‑lipoxygenase (5-LOX) metabolites 5‑oxo‑6,8,11,14‑eicosatetraenoic acid (5-oxo-ETE) in the ovary, which could lead to suppression of AA cyclooxygenase (COX) metabolite prostaglandin F2α (PGF2α). It is believed that AA induced oocyte maturation, while 5-oxo-ETE and related metabolites in purinergic signaling promoted ovulation. Whereas, the suppression of PGF2α production might block spawning and damaged follicular tissue digestion, which explained the oocytes over-ripening and atretic follicles in the treated ovary. Overall, our results suggested that DDG exposure induced zebrafish oocyte maturation and ovulation but led to oocytes over-ripening via the AA metabolic pathway and purinergic signaling.
Identifiants
pubmed: 31078873
pii: S0160-4120(19)30150-3
doi: 10.1016/j.envint.2019.04.059
pii:
doi:
Substances chimiques
Endocrine Disruptors
0
Progestins
0
Water Pollutants, Chemical
0
Dydrogesterone
90I02KLE8K
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
390-398Informations de copyright
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.